Daiwa Securities Group
EWTX icon

Daiwa Securities Group’s Edgewise Therapeutics EWTX Stock Holding History

Daiwa Securities Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-344
Closed -$9K – 1270
2025
Q4 		$9K Hold
344
– – ﹤0.01% 1191
2025
Q3 		$6K Hold
344
– – ﹤0.01% 1188
2025
Q2 		$5K Hold
344
– – ﹤0.01% 1157
2025
Q1 		$8K Hold
344
– – ﹤0.01% 1103
2024
Q4 		$9K Hold
344
– – ﹤0.01% 1125
2024
Q3 		$9K Hold
344
– – ﹤0.01% 1135
2024
Q2 		$6K Hold
344
– – ﹤0.01% 1186
2024
Q1 		$6K Buy
344
+90
+35% +$1.43K ﹤0.01% 1194
2023
Q4 		$3K Hold
254
– – ﹤0.01% 1243
2023
Q3 		$1K Hold
254
– – ﹤0.01% 1249
2023
Q2 		$2K Hold
254
– – ﹤0.01% 1229
2023
Q1 		$2K Hold
254
– – ﹤0.01% 1212
2022
Q4 		$2K Buy
254
+110
+76% +$1.03K ﹤0.01% 1223
2022
Q3 		$1K Hold
144
– – ﹤0.01% 1284
2022
Q2 		$1K Hold
144
– – ﹤0.01% 1285
2022
Q1 		$1K Hold
144
– – ﹤0.01% 1305
2021
Q4 		$2K Buy
+144
New +$2.59K ﹤0.01% 1280

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Daiwa Securities Group's EWTX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 344 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in EWTX in Q4 2021 and held it in 17 quarters. The position peaked at $9K in Q4 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 344 Edgewise Therapeutics shares in Q1 2026, an estimated $9K.
  • Daiwa Securities Group first reported a position in Edgewise Therapeutics in Q4 2021 and held it in 17 quarters.
  • Daiwa Securities Group's Edgewise Therapeutics position peaked at $9K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.